Clinical Trial Update: A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients

View source ↗

Summary

This clinical trial investigates how treatment duration and CYP2C19 genetic polymorphisms influence the eradication rate of standard triple therapy for Helicoba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Helicobacter Pylori Infection | Status: UNKNOWN